PMC8452419_01
Clinical course. HU, hydroxyurea; CyA, cyclosporine; BU, busulfan; Hb, hemoglobin; WBC, white blood cell; PLT, platelets.
CRIHEM2021-5237986.001.jpg
PMC8452419_01_CRIHEM2021-5237986.001.jpg
fig1
Echocardiography showed a slight decrease in pericardial effusion in January 2019. (Figure 1).
Imaging revealed heart enlargement, massive pericardial fluid, and a small amount of pleural fluid retention.
CRIHEM2021-5237986.002.jpg
PMC8452419_01_CRIHEM2021-5237986.002.jpg
fig2
He was admitted to our hospital in April, 2020, because of severe dyspnea. He was diagnosed with cardiac tamponade caused by a large pericardial effusion (Figure 2).
Cytological pericardial effusion findings. (a) Pap staining (x40). Cell block with ((b)-(e)) immunocytochemical findings. (b) CD20. (c) Ki-67 (MIB-1 index 50%). (d) EBER. (e) MUM-1 ((b)-(e) x40).
CRIHEM2021-5237986.003.jpg
PMC8452419_01_CRIHEM2021-5237986.003.jpg
fig3
IV pericardial fluid cytodiagnosis. Immunohistochemical staining of the cell block was positive for CD20, EBER, and MUM-1, and 50% of MIB-1 (Figure 3); HHV-8 DNA was negative, and we diagnosed the patient with PEL-LL.
Image of plain computed tomography. Massive ascites and increased liver density.
CRIHEM2021-5237986.004.jpg
PMC8452419_01_CRIHEM2021-5237986.004.jpg
fig4
However, massive ascites was observed on October 31, 2020 (Figure 4).